Edward Burd

Edward Burd

Company: BiomX

Job title: Senior Vice President Regulatory Affairs


A Corporation Perspective on Developing Bacteriophage Therapies in 3 Questions: What Do We Know, What is New, What Remains to be Determined? 9:30 am

What is known: how phage therapeutics fit into existing regulatory frameworks What is new: manufacturing challenges for pathogenic producer cell lines and product safety What regulatory approaches remain to be determined: e.g. novel clinical trial approaches, long term safety, product evolution to keep in front of phage resistanceRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.